DSIJ Mindshare

According to the financials, DMR has a market cap of Rs 16.55 crore with a 1-year stock price CAGR of 75 per cent. The net sales increased by 23.82 per cent to Rs 4.38 crore and the net profit increased by 12.81 per cent to Rs 0.77 crore in FY23 over FY22.

Earum Pharmaceuticals has a market cap of Rs 36.82 crore. The company reported positive numbers in its both quarterly results and annual results. The stock has a PE of 18.60x whereas the industry PE is 30x.

Shares of the company gained more than 9 per cent in the last six months.

According to the half-yearly and annual financial statements, the firm reported positive results. In H2FY23 net sales increased by 44.12 per cent and net profit increased by 12.50 per cent compared to H2FY22. The net sales increased by 66.85 per cent and net profit increased by 60 per cent in FY23 over FY22. The stock has a ROE of 25 per cent and a ROCE of 27 per cent.

The company is expanding its business and also execution of orders has consistently increased during the last two quarters while being at the forefront of the government scheme rollout for smart metering. The net sales increased by per cent to Rs 1,262 crore and net profit skyrocketed by per cent to Rs 30 crore in FY23 over FY22.